A Drug Regulatory Specialist serves as a key liaison between product developers and regulatory authorities, ensuring that therapeutic products comply with all applicable laws and guidelines. Their role involves compiling and submitting comprehensive documentation required for regulatory approvals, such as Investigational New Drug (IND) applications, New Drug Applications (NDA), and Marketing Authorization Applications (MAA). They carefully interpret complex regulatory requirements from agencies worldwide and provide strategic advice to align product development activities accordingly. By managing timelines and coordinating cross-functional teams, these specialists help streamline the approval process and minimize regulatory risks. Their work ensures that products meet the highest standards for safety, efficacy, and quality before reaching patients.
Beyond submissions, Drug Regulatory Specialists continuously monitor changes in regulations and guidance documents to ensure ongoing compliance throughout a product’s lifecycle. They assist in preparing responses to regulatory queries, supporting inspections and audits, and updating product information when necessary. Their expertise in navigating the global regulatory environment supports successful product launches and market access. This role demands strong communication skills, attention to detail, and the ability to adapt to evolving regulatory frameworks. Ultimately, their contributions are vital in bringing safe and effective treatments to patients while maintaining the integrity of the regulatory process.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico